Top

Published in:

01-05-2009 | Review Article

Dissemination research in cancer control: where are we and where should we go?

Authors: Deborah J. Bowen, Glorian Sorensen, Bryan J. Weiner, Marci Campbell, Karen Emmons, Cathy Melvin

Published in: Cancer Causes & Control | Issue 4/2009

Abstract

Dissemination of evidence-based programs and policies is a critical final step in reducing the burden of cancer in the general public. Yet, we have not been fully successful to date in improving clinical or public health practice by disseminating programs found to be effective in research. Therefore, research is needed into the dissemination process and outcomes to enable better efforts in the future. This paper explores the definitions and models used for dissemination, the designs of dissemination studies, and possible research questions in dissemination research, all focused on cancer prevention and control. We hope that this paper will encourage dissemination research in our field.

Lomas J (1991) Words without action? The production, dissemination, and impact of consensus recommendations. Annu Rev Public Health 12:41–65. doi:10.1146/annurev.pu.12.050191.000353 PubMedCrossRef

Rabin BA, Brownson R, Haire-Joshu D, Kreuter M, Weaver N (2008) A glossary of dissemination and implementation research in health. J Public Health Manag Pract 14:117–123PubMed

Haynes B, Haines A (1998) Barriers and bridges to evidence based clinical practice. Br Med J 317(7153):273–276

McQueen DV (2001) Strengthening the evidence base for health promotion. Health Promot Int 16(3):261–268. doi:10.1093/heapro/16.3.261 PubMedCrossRef

Glasgow RE, Emmons KM (2007) How can we increase translation of research into practice? Types of evidence needed. Annu Rev Public Health 28:413–433. doi:10.1146/annurev.publhealth.28.021406.144145 PubMedCrossRef

Greenwald P, Cullen JW (1984) A scientific approach to cancer control. Cancer 25:236–244

Flay BR (1986) Efficacy and effectiveness trials (and other phases of research) in the development of health promotion programs. Prev Med 15(5):451–474. doi:10.1016/0091-7435(86)90024-1 PubMedCrossRef

Cook TD (2000) Validity and social experimentation. In: Bickman L (ed) Toward a practical theory of external validity. Sage, Thousand Oaks, pp 3–43

Rabin BA, Brownson RC, Kerner JF, Glasgow RE (2006) Methodologic challenges in disseminating evidence-based interventions to promote physical activity. Am J Prev Med 31(4 Suppl):S24–S34. doi:10.1016/j.amepre.2006.06.009 PubMedCrossRef

10.

Koepsell TD, Wagner EH, Cheadle AC, Patrick DL, Martin DC, Diehr PH et al (1992) Selected methodological issues in evaluating community-based health promotion and disease prevention programs. Annu Rev Public Health 13:31–57. doi:10.1146/annurev.pu.13.050192.000335 PubMedCrossRef

11.

Susser M (1995) Editorial: the tribulations of trials—interventions in communities. Am J Public Health 85:156–158. doi:10.2105/AJPH.85.2.156 PubMedCrossRef

12.

Goldenhar LM, LaMontagne AD, Katz T, Heaney C, Landsbergis P (2001) The intervention research process in occupational safety and health: an overview for the National Occupational Research Agenda Intervention Effectiveness Research Team. J Occup Environ Med 43(7):616–622. doi:10.1097/00043764-200107000-00008 PubMedCrossRef

13.

Murray DM (1998) Design and analysis of group randomized trials. Oxford University Press, New York

14.

Sorensen G, Emmons K, Hunt MK, Johnston D (1998) Implications of the results of community intervention trials. Annu Rev Public Health 19:379–416. doi:10.1146/annurev.publhealth.19.1.379 PubMedCrossRef

15.

Shadish WR, Cook TD, Campell DT (2002) Experimental and quasi experimental design for generalized causal inference. Houghton, Boston

16.

Glasgow RE, Lichtenstein E, Marcus AC (2003) Why don’t we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition. Am J Public Health 93(8):1261–1267. doi:10.2105/AJPH.93.8.1261 PubMedCrossRef

17.

National Heart Lung and Blood Institute (1983) Guidelines for demonstration and education research grants. National Heart Lung and Blood Institute, Washington, DC

18.

Mrazek P, Haggerty R (eds) (1994) Reducing risks for mental disorders. National Academy Press, Washington, DC

19.

McKinlay JB (1993) The promotion of health through planned sociopolitical change: challenges for research and policy. Soc Sci Med 36(2):109–117. doi:10.1016/0277-9536(93)90202-F PubMedCrossRef

20.

Valente TM (2006) Need, demand, and external validity in dissemination of physical activity programs. Am J Prev Med 31(4 Suppl):5–7. doi:10.1016/j.amepre.2006.06.012 CrossRef

21.

Fisher EB (1995) Editorial: the results of the COMMIT trial. Am J Public Health 85(2):159–160. doi:10.2105/AJPH.85.2.159 PubMedCrossRef

22.

Wandersman A (2003) Community science: bridging the gap between science and practice with community-centered models. Am J Community Psychol 31(3/4):227–241. doi:10.1023/A:1023954503247 PubMedCrossRef

23.

Green LW (2001) From research to “best practices” in other settings and populations. Am J Health Behav 25(3):165–178PubMed

24.

Glasgow RE, Green LW, Klesges LM, Abrams DB, Fisher EB, Goldstein MG et al (2006) External validity: we need to do more. Ann Behav Med 31(2):105–108. doi:10.1207/s15324796abm3102_1 PubMedCrossRef

25.

Best A (2007) Organizational frameworks for knowledge development, exchange and implementation. KDEI Frameworks

26.

Brownson RC, Gurney JG, Land GH (1999) Evidence-based decision making in public health. J Public Health Manag Pract 5(5):86–97PubMed

27.

Petitti DB (1994) Meta-analysis, decision analysis, and cost-effectiveness analysis: methods for quantitative synthesis in medicine. Oxford University Press, New York

28.

Best A, Clark PI, Leischow SJ, Trochim W (eds) (2007) Greater than the sum: systems thinking in tobacco control. Tobacco control monograph no. 18. U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda, MD, NIH Pub. No. 06-6085

29.

Brownson RC (1998) Epidemiology and health policy. In: Brownson RC, Petitti DB (eds) Applied epidemiology: theory to practice. Oxford University Press, New York

30.

Glass GV (1976) Primary, secondary and meta-analysis of research. Educ Res 5:3–8

31.

Des Jarlais DC, Lyles C, Crepaz N (2004) Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health 94(3):361–366. doi:10.2105/AJPH.94.3.361 PubMedCrossRef

32.

Zaza S, Briss PA, Harris KW (eds) (2005) The guide to community preventive Services: what works to promote health? (Task Force on Community Preventive Services). Oxford University Press, New York

33.

Briss PA, Brownson RC, Fielding JE, Zaza S (2004) Developing and using the Guide to Community Preventive Services: lessons learned about evidence-based public health. Annu Rev Public Health 25:281–302. doi:10.1146/annurev.publhealth.25.050503.153933 PubMedCrossRef

34.

Missouri Department of Health and Senior Services. Intervention Missouri information for community assessment. DHSS, MO

35.

New Hampshire Institute for Public Health Policy and Practice (2006) E-roadmap to evidence-based public health practice

36.

Victora CG, Habicht JP, Bryce J (2004) Evidence-based public health: moving beyond randomized trials. Am J Public Health 94(3):400–405. doi:10.2105/AJPH.94.3.400 PubMedCrossRef

37.

McKleroy VSGJ, Cummings B, Jones P, Harshbarger C, Collins C, Gelaude D, Carey JW (2006) ADAPT Team Adapting evidence-based behavioral interventions for new settings and target populations. AIDS Educ Prev 18(4 Suppl A):59–73PubMedCrossRef

38.

Dearing JW, Maibach EW, Buller DB (2006) A convergent diffusion and social marketing approach for disseminating proven approaches to physical activity promotion. Am J Prev Med 31(4 Suppl):8–10. doi:10.1016/j.amepre.2006.06.018

39.

Price RH, Lorioin RP (1989) Prevention programming as organizational reinvention: from research to implementation. In: Silverman MM, Anthony V (eds) Prevention of mental disorders, alcohol and drug use in children and adolescents. DHHS, Rockville, pp 97–123

40.

Pentz MA, Trebow E (1997) Implementation issues in drug abuse prevention research. Subst Use Misuse 32(12&13):1655–1660. doi:10.3109/10826089709035560 CrossRef

41.

Pentz MA, Trebow E, Hansen WB, MacKinnon DP, Dwyer JH, Flay BR et al (1990) Effects of program implementation on adolescent drug use behavior: The Midwestern Prevention Project (MPP). Eval Rev 14(3):264–289. doi:10.1177/0193841X9001400303 CrossRef

42.

Florin P, Wandersman A (1990) An introduction to citizen participation, voluntary organizations, and community development: insights for empowerment through research. Am J Community Psychol 18:41–53. doi:10.1007/BF00922688 CrossRef

43.

Pentz MA (1998) Research to practice in community-based prevention trials. In: Programs and abstracts, 1998. National Institutes of Health, pp 82–83

44.

McKleroy VS, Galbraith JS, Cummings B, Jones P, Harshbarger C, Collins C et al (2006) Adapting evidence-based behavioral interventions for new settings and target populations. AIDS Educ Prev 18(Suppl A):59–73. doi:10.1521/aeap.2006.18.supp.59 PubMedCrossRef

45.

Kottke TE, Pronk NP (2006) Physical activity optimizing practice through research. Am J Prev Med 31(4 Suppl):S8–S10. doi:10.1016/j.amepre.2006.06.011 PubMedCrossRef

46.

Owen N, Glanz K, Sallis JF, Kelder SH (2006) Evidence-based approaches to dissemination and diffusion of physical activity interventions. Am J Prev Med 31(4 Suppl):35–44. doi:10.1016/j.amepre.2006.06.008 CrossRef

47.

MA GlasgowRE, Bull SS, Wilson KM (2004) Disseminating effective cancer screening interventions. Cancer 101(5 Suppl):1239–1250

48.

Hawking S (1996) The illustrated a brief history of time. Bantam Books P15, New York

49.

Ford DH, Lerner RM (1992) Developmental systems theory: an integrated approach. Sage Publications, New York

50.

Rogers E (1995) Diffusion of innovations. Free Press, New York

51.

Greenhalgh T (2004) Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q 82(4):581–629. doi:10.1111/j.0887-378X.2004.00325.x PubMedCrossRef

52.

Dearing J (2008) Evolution of diffusion and dissemination theory. J Public Health Manag Pract 14(2):99–108PubMed

53.

PA Estabrooks, RE Glasgow (2006) Translating effective clinic-based physical activity interventions into practice. Am J Prev Med 31(4):S45–S56. doi:10.1016/j.amepre.2006.06.019 CrossRef

54.

Bracht N, Kingsbury L, Rissel C (1999) A five stage community organization model for health promotion: empowerment and partnership strategies. In: Bracht N (ed) Health promotion at the community level: new advances. Sage Publications, Thousand Oaks

55.

Kotler P, Zaltman G (1971) JSTOR social marketing: an approach to planned social change. J Mark 35:3–12PubMedCrossRef

56.

Glasgow RE, Vogt TM, Boles SM (1999) Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health 89(9):1322–1327. doi:10.2105/AJPH.89.9.1322 PubMedCrossRef

57.

Kerner J, Guirguis-Blake J, Hennessy KD et al (2005) Translating research into improved outcomes in comprehensive cancer control. Cancer Causes Control 16(Suppl 1):27–40. doi:10.1007/s10552-005-0488-y PubMedCrossRef

58.

Orleans C (2005) The behavior change consortium: expanding the boundaries and impact of the health behavior change research. Ann Behav Med 29(Suppl 1):76–79. doi:10.1207/s15324796abm2902s_11 PubMedCrossRef

59.

Bonomi AE, Wagner EH, Glasgow RE, VonKorff M (2002) Assessment of chronic illness care (ACIC): a practical tool to measure quality improvement. Health Serv Res 37(3):791–820. doi:10.1111/1475-6773.00049 PubMedCrossRef

60.

Mercer SL, DeVinney BJ, Fine LJ, Green LW, Dougherty D (2007) Study designs for effectiveness and translation research: identifying trade-offs. Am J Prev Med 33(2):139–154. doi:10.1016/j.amepre.2007.04.005 PubMedCrossRef

61.

Eccles M, Grimshaw J, Campbell M, Ramsay C (2003) Research designs for studies evaluating the effectiveness of change and improvement strategies. Qual Saf Health Care 12(1):47–52. doi:10.1136/qhc.12.1.47 PubMedCrossRef

62.

Gilbody S, Whitty P (2002) Improving the delivery and organisation of mental health services: beyond the conventional randomised controlled trial. Br J Psychiatry 180:13–18. doi:10.1192/bjp.180.1.13 PubMedCrossRef

63.

Grimshaw J, Campbell M, Eccles M, Steen N (2000) Experimental and quasi-experimental designs for evaluating guideline implementation strategies. Fam Pract 17(Suppl 1):S11–S16. doi:10.1093/fampra/17.suppl_1.S11 PubMedCrossRef

64.

Neuhauser D, Diaz M (2007) Quality improvement research: are randomised trials necessary? Qual Saf Health Care 16(1):77–80. doi:10.1136/qshc.2006.021584 PubMedCrossRef

65.

Rosen L, Manor O, Engelhard D, Zucker D (2006) In defense of the randomized controlled trial for health promotion research. Am J Public Health 96(7):1181–1186. doi:10.2105/AJPH.2004.061713 PubMedCrossRef

66.

Sanson-Fisher RW, Bonevski B, Green LW, D’Este C (2007) Limitations of the randomized controlled trial in evaluating population-based health interventions. Am J Prev Med 33(2):155–161. doi:10.1016/j.amepre.2007.04.007 PubMedCrossRef

67.

Trochim WMK (2001) The research methods knowledge base, 1st edn. Atomic Dog Publishing, Cincinnati

68.

Bracht GH, Glass GV (1968) External validity of experiments. Am Educ Res J 5(4):437–474

69.

Valente TW (2007) Identifying opinion leaders to promote behavior change. Health Educ Behav 34(6):881–896. doi:10.1177/1090198106297855 PubMedCrossRef

70.

Colditz G (2008) Translating science to practice: community and academic perspectives. J Public Health Manag Pract 14:144–149PubMed

Title: Dissemination research in cancer control: where are we and where should we go?
Authors: Deborah J. Bowen
Glorian Sorensen
Bryan J. Weiner
Marci Campbell
Karen Emmons
Cathy Melvin
Publication date: 01-05-2009
Publisher: Springer Netherlands
Published in: Cancer Causes & Control / Issue 4/2009
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-009-9308-0

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2009

Authors’ reply

Maximizing resources to study an uncommon cancer: E2C2—Epidemiology of Endometrial Cancer Consortium

Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study

Association of serum phospholipid fatty acids with breast cancer risk among postmenopausal cigarette smokers

Genetic variants in frizzled-related protein (FRZB) and the risk of colorectal neoplasia

Systematic review of human papillomavirus prevalence in invasive penile cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer